Cargando…
Soluble ST2 plasma concentrations predict mortality in severe sepsis
PURPOSE: Patients with sepsis—after surviving the initial hyperinflammatory phase—display features consistent with immunosuppression, including hyporesponsiveness of immunocompetent cells to bacterial agents. Immunosuppression is thought to be facilitated by negative regulators of toll-like receptor...
Autores principales: | Hoogerwerf, Jacobien J., Tanck, Michael W. T., van Zoelen, Marieke A. D., Wittebole, Xavier, Laterre, Pierre-François, van der Poll, Tom |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837188/ https://www.ncbi.nlm.nih.gov/pubmed/20151106 http://dx.doi.org/10.1007/s00134-010-1773-0 |
Ejemplares similares
-
Targeting RAGE in sepsis
por: van Zoelen, Marieke AD, et al.
Publicado: (2008) -
Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis – practical aspects at the bedside and patient identification
por: Laterre, Pierre-François, et al.
Publicado: (2003) -
The role of receptor for advanced glycation endproducts (RAGE) in infection
por: van Zoelen , Marieke AD, et al.
Publicado: (2011) -
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock
por: Taccone, Fabio Silvio, et al.
Publicado: (2010) -
Toll-like Receptor 4 Modulation as a Strategy to Treat Sepsis
por: Wittebole, X., et al.
Publicado: (2010)